Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update

Go back to Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update

SAGE Therapeutics (SAGE) Misses Q2 EPS by 21c

August 3, 2017 5:38 PM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($1.88), $0.21 worse than the analyst estimate of ($1.67).

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More